1. Pfizer, BioNTech Halt U.S. COVID-19 Vaccine Trial Amid Political Pushback, Weak Demand
Pfizer and BioNTech have abruptly halted a key U.S. clinical trial for their updated COVID-19 vaccine, a significant operational setback driven by political headwinds and collapsing public interest. The move signals a deeper crisis for vaccine manufacturers as they navigate an increasingly hostile and indifferent post-...